rs61737906

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000093.5(COL5A1):​c.4065C>T​(p.Pro1355Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000945 in 1,613,604 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0015 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00089 ( 17 hom. )

Consequence

COL5A1
NM_000093.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -2.54

Publications

1 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, ClinGen, Orphanet
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 9-134815626-C-T is Benign according to our data. Variant chr9-134815626-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136887.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.54 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00151 (230/152248) while in subpopulation AFR AF = 0.00161 (67/41542). AF 95% confidence interval is 0.0013. There are 2 homozygotes in GnomAd4. There are 110 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 230 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000093.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL5A1
NM_000093.5
MANE Select
c.4065C>Tp.Pro1355Pro
synonymous
Exon 51 of 66NP_000084.3
COL5A1
NM_001278074.1
c.4065C>Tp.Pro1355Pro
synonymous
Exon 51 of 66NP_001265003.1P20908-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL5A1
ENST00000371817.8
TSL:1 MANE Select
c.4065C>Tp.Pro1355Pro
synonymous
Exon 51 of 66ENSP00000360882.3P20908-1
COL5A1
ENST00000371820.4
TSL:2
c.4065C>Tp.Pro1355Pro
synonymous
Exon 51 of 66ENSP00000360885.4P20908-2
COL5A1
ENST00000950240.1
c.4056C>Tp.Pro1352Pro
synonymous
Exon 51 of 66ENSP00000620299.1

Frequencies

GnomAD3 genomes
AF:
0.00151
AC:
230
AN:
152130
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.0360
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000368
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00177
AC:
440
AN:
248510
AF XY:
0.00162
show subpopulations
Gnomad AFR exome
AF:
0.00113
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.0338
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000517
Gnomad OTH exome
AF:
0.00297
GnomAD4 exome
AF:
0.000886
AC:
1295
AN:
1461356
Hom.:
17
Cov.:
32
AF XY:
0.000898
AC XY:
653
AN XY:
726938
show subpopulations
African (AFR)
AF:
0.00134
AC:
45
AN:
33478
American (AMR)
AF:
0.000246
AC:
11
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0328
AC:
857
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86106
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53258
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5754
European-Non Finnish (NFE)
AF:
0.000176
AC:
196
AN:
1111890
Other (OTH)
AF:
0.00300
AC:
181
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
87
174
262
349
436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00151
AC:
230
AN:
152248
Hom.:
2
Cov.:
33
AF XY:
0.00148
AC XY:
110
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00161
AC:
67
AN:
41542
American (AMR)
AF:
0.000392
AC:
6
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0360
AC:
125
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000368
AC:
25
AN:
68012
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00332
Hom.:
3
Bravo
AF:
0.00164
EpiCase
AF:
0.000600
EpiControl
AF:
0.000771

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Ehlers-Danlos syndrome, classic type (2)
-
-
2
Ehlers-Danlos syndrome, classic type, 1 (2)
-
-
1
Connective tissue disorder (1)
-
-
1
Ehlers-Danlos syndrome (1)
-
-
1
Ehlers-Danlos syndrome type 7A (1)
-
-
1
Familial thoracic aortic aneurysm and aortic dissection (1)
-
-
1
Fibromuscular dysplasia, multifocal (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
1.1
DANN
Benign
0.46
PhyloP100
-2.5
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61737906; hg19: chr9-137707472; COSMIC: COSV100879787; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.